Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

Similar articles for PubMed (Select 11559480)

1.

Managing comorbid schizophrenia and substance abuse.

Drake RE, Mueser KT.

Curr Psychiatry Rep. 2001 Oct;3(5):418-22. Review.

PMID:
11559480
2.

A review of treatments for people with severe mental illnesses and co-occurring substance use disorders.

Drake RE, Mueser KT, Brunette MF, McHugo GJ.

Psychiatr Rehabil J. 2004 Spring;27(4):360-74. Review.

PMID:
15222148
3.

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.

Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J.

Am J Psychiatry. 2001 Oct;158(10):1706-13.

PMID:
11579006
4.

Implementing dual diagnosis services for clients with severe mental illness.

Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L.

Psychiatr Serv. 2001 Apr;52(4):469-76. Review.

PMID:
11274491
5.
6.

Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.

Horsfall J, Cleary M, Hunt GE, Walter G.

Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Review.

PMID:
19205964
7.

Substance abuse and the management of medication nonadherence in schizophrenia.

Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.

J Nerv Ment Dis. 2006 Jun;194(6):454-7.

PMID:
16772865
8.
10.

Psychosocial approaches to dual diagnosis.

Drake RE, Mueser KT.

Schizophr Bull. 2000;26(1):105-18. Review.

11.

Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.

Green AI.

J Clin Psychiatry. 2006;67 Suppl 7:31-5; quiz 36-7. Review.

PMID:
16961422
12.

Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders.

Xie H, McHugo GJ, Helmstetter BS, Drake RE.

Schizophr Res. 2005 Jun 15;75(2-3):337-48.

PMID:
15885525
13.

A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders.

Brunette MF, Mueser KT, Drake RE.

Drug Alcohol Rev. 2004 Dec;23(4):471-81. Review.

PMID:
15763752
14.

Schizophrenia and comorbid substance use disorder: effects of antipsychotics.

Green AI.

J Clin Psychiatry. 2005;66 Suppl 6:21-6. Review.

PMID:
16107180
15.

Perceived unmet need for mental health care for Canadians with co-occurring mental and substance use disorders.

Urbanoski KA, Cairney J, Bassani DG, Rush BR.

Psychiatr Serv. 2008 Mar;59(3):283-9. doi: 10.1176/appi.ps.59.3.283.

PMID:
18308909
16.

Which substance abuse treatment facilities offer dual diagnosis programs?

Mojtabai R.

Am J Drug Alcohol Abuse. 2004 Aug;30(3):525-36.

PMID:
15540491
18.

Reduction of comorbid substance abuse with clozapine.

Marcus P, Snyder R.

Am J Psychiatry. 1995 Jun;152(6):959. No abstract available.

PMID:
7755141
19.

Behavioral interventions for dual-diagnosis patients.

Goldsmith RJ, Garlapati V.

Psychiatr Clin North Am. 2004 Dec;27(4):709-25. Review.

PMID:
15550289
20.

Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.

Clark RE, Xie H, Brunette MF.

J Clin Psychiatry. 2004 Feb;65(2):151-5.

PMID:
15003066
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk